plerixafor has been researched along with Pancreatic Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, S; Carter, JE; Gorman, GS; Khan, MA; Khushman, M; Patel, GK; Singh, AP; Singh, S; Srivastava, SK; Zubair, H | 1 |
| Barmpounakis, P; Basu, B; Bax, L; Biasci, D; Brais, R; Connell, CM; Fearon, DT; Gale, D; Gallagher, FA; Gao, Y; Godfrey, E; Gopinathan, A; Hudecova, I; Isherwood, C; Janowitz, T; Jodrell, DI; Johnson, TI; Magiera, L; Mir, F; Pawula, M; Popa, EC; Richards, FM; Rosenfeld, N; Smoragiewicz, M; Thaventhiran, JED; Wang, Z | 1 |
| Fearon, DT; Janowitz, T | 1 |
| Hwang, RF; Logsdon, CD; Ma, Y; Ullrich, SE | 1 |
| Caballero, OL; Chan, DS; Connell, CM; Deonarine, A; Fearon, DT; Feig, C; Janowitz, T; Jodrell, DI; Jones, JO; Kraman, M; Roberts, EW; Teichmann, SA; Tuveson, DA; Wells, RJ; Zhao, Q | 1 |
| Jiang, TH; Mao, AW; Peng, J; Sun, XJ | 1 |
| Guo, JC; Li, J; Liang, ZY; Yang, JY; You, L; Zhang, TP; Zhang, ZG; Zhao, YP; Zhou, L; Zhou, WX | 1 |
| Huang, SM; Jeon, SB; Kim, JM; Kim, SJ; Koh, SS; Lee, Y; Lim, DS; Park, EH; Park, HD | 1 |
| Bhardwaj, A; Owen, LB; Singh, AP; Singh, S; Srivastava, SK | 1 |
9 other study(ies) available for plerixafor and Pancreatic Neoplasms
| Article | Year |
|---|---|
Co-targeting of CXCR4 and hedgehog pathways disrupts tumor-stromal crosstalk and improves chemotherapeutic efficacy in pancreatic cancer.
Topics: Anilides; Animals; Antimetabolites, Antineoplastic; Benzylamines; Cell Communication; Cell Survival; Coculture Techniques; Cyclams; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Hedgehog Proteins; Heterocyclic Compounds; Humans; Mice; Mice, Nude; Pancreatic Neoplasms; Pancreatic Stellate Cells; Pyridines; Reactive Oxygen Species; Receptors, CXCR4; RNA Interference; RNA, Small Interfering; Signal Transduction | 2020 |
CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response.
Topics: Aged; Benzylamines; Carcinoma, Pancreatic Ductal; Chemokine CXCL12; Colorectal Neoplasms; Cyclams; Female; Heterocyclic Compounds; Humans; Immunity; Immunotherapy; Male; Middle Aged; Pancreas; Pancreatic Neoplasms; Receptors, CCR2; Receptors, CXCR3; Receptors, CXCR4; Receptors, CXCR5; Receptors, CXCR6; Receptors, Interleukin-8A; Signal Transduction; Tumor Microenvironment | 2020 |
AMD3100/Plerixafor overcomes immune inhibition by the CXCL12-KRT19 coating on pancreatic and colorectal cancer cells.
Topics: Benzylamines; Chemokine CXCL12; Colorectal Neoplasms; Cyclams; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Pancreatic Neoplasms; Receptors, CXCR4 | 2021 |
Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Benzylamines; Carcinoma, Pancreatic Ductal; Cell Communication; Cell Degranulation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Coculture Techniques; Culture Media, Conditioned; Cyclams; Epithelial Cells; Heterocyclic Compounds; Humans; Interleukin-13; Mast Cells; Mice; Mice, Inbred C57BL; Pancreatic Neoplasms; Pancreatic Stellate Cells; Receptors, CXCR4; Stromal Cells; Tryptases; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2013 |
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.
Topics: Analysis of Variance; Animals; Base Sequence; Benzylamines; Carcinoma, Pancreatic Ductal; Chemokine CXCL12; Cyclams; Endopeptidases; Enzyme-Linked Immunospot Assay; Fibroblasts; Flow Cytometry; Fluorescent Antibody Technique; Gelatinases; Heterocyclic Compounds; Immunohistochemistry; Immunotherapy; Membrane Proteins; Mice; Molecular Sequence Data; Pancreatic Neoplasms; Sequence Analysis, RNA; Serine Endopeptidases; Tumor Escape | 2013 |
Application of chemokine receptor antagonist with stents reduces local inflammation and suppresses cancer growth.
Topics: Animals; Benzylamines; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL12; Cyclams; Heterocyclic Compounds; Humans; Inflammation; Mice; Neoplasms, Experimental; Pancreatic Neoplasms; Receptors, CXCR4; Signal Transduction; Stents; Xenograft Model Antitumor Assays | 2015 |
CXCL12-CXCR7 axis contributes to the invasive phenotype of pancreatic cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Benzylamines; Cell Movement; Cell Proliferation; Chemokine CXCL12; Cyclams; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Male; Mice; Mice, Nude; Middle Aged; Neoplasm Invasiveness; Neoplasm Transplantation; Pancreatic Neoplasms; Prognosis; Receptors, CXCR; Signal Transduction; TOR Serine-Threonine Kinases | 2016 |
PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression.
Topics: Animals; Benzylamines; Blotting, Western; Cell Line, Tumor; Cell Movement; Cyclams; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Lectins; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms, Experimental; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Transplantation, Heterologous; Up-Regulation | 2010 |
CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy.
Topics: Antimetabolites, Antineoplastic; Benzylamines; beta Catenin; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Deoxycytidine; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; Focal Adhesion Protein-Tyrosine Kinases; Gemcitabine; Heterocyclic Compounds; Humans; NF-kappa B; Pancreatic Neoplasms; Proto-Oncogene Proteins c-akt; Receptors, CXCR4; Signal Transduction | 2010 |